MESIROW FINANCIAL INVESTMENT MANAGEMENT Equity & Fixed Income Makes New Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI)

MESIROW FINANCIAL INVESTMENT MANAGEMENT Equity & Fixed Income acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIGet Rating) during the first quarter, HoldingsChannel reports. The firm acquired 3,240 shares of the exchange traded fund’s stock, valued at approximately $291,000.

A number of other institutional investors have also recently bought and sold shares of the business. Canada Pension Plan Investment Board lifted its position in SPDR S&P Biotech ETF by 200.0% during the 4th quarter. Canada Pension Plan Investment Board now owns 1,200,000 shares of the exchange traded fund’s stock worth $134,352,000 after buying an additional 800,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its stake in shares of SPDR S&P Biotech ETF by 48.4% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 848,000 shares of the exchange traded fund’s stock valued at $94,942,000 after acquiring an additional 276,650 shares during the period. Phoenix Holdings Ltd. boosted its holdings in SPDR S&P Biotech ETF by 40.8% in the fourth quarter. Phoenix Holdings Ltd. now owns 799,505 shares of the exchange traded fund’s stock valued at $89,512,000 after acquiring an additional 231,855 shares during the last quarter. Bank Julius Baer & Co. Ltd Zurich grew its position in shares of SPDR S&P Biotech ETF by 29.3% during the 4th quarter. Bank Julius Baer & Co. Ltd Zurich now owns 728,810 shares of the exchange traded fund’s stock worth $81,598,000 after buying an additional 165,265 shares during the period. Finally, LPL Financial LLC lifted its stake in shares of SPDR S&P Biotech ETF by 7.9% in the 4th quarter. LPL Financial LLC now owns 578,115 shares of the exchange traded fund’s stock valued at $64,726,000 after purchasing an additional 42,152 shares during the period.

SPDR S&P Biotech ETF Stock Up 4.0 %

Shares of SPDR S&P Biotech ETF stock traded up $3.59 during trading on Friday, reaching $92.30. 19,812,453 shares of the company were exchanged, compared to its average volume of 14,125,886. The business has a 50-day moving average price of $76.52 and a 200-day moving average price of $81.85. SPDR S&P Biotech ETF has a twelve month low of $61.78 and a twelve month high of $136.61.

SPDR S&P Biotech ETF Profile

(Get Rating)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Stories

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIGet Rating).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.